Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Santhera Pharmaceuticals)"
Count: 26
Selected: 0
NCT IDTitle
NCT04381091Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study
NCT03748199Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients With CF
NCT03603288Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
NCT03433807Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)
NCT02887443A Study to Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate
NCT02814019A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
NCT02796274Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)
NCT02774005Study to Assess the Efficacy and Safety of Raxone in LHON Patients
NCT02771379Post Authorisation Safety Study With Raxone in LHON Patients
NCT01892943Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey
NCT01805024Congenital Muscular Dystrophy Ascending Multiple Dose Cohort Study Analyzing Pharmacokinetics at Three Dose Levels In Children and Adolescents With Assessment of Safety and Tolerability of Omigapil (CALLISTO)
NCT01495715Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
NCT01421381RHODOS Follow-up Single-visit Study
NCT01303406Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
NCT01027884Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
NCT00993967Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)
NCT00905268A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
NCT00758225Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
NCT00747487Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy
NCT00697073Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
NCT00654784Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy
NCT00537680Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
NCT00887562Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes
NCT00758849Fipamezole in Neurogenic Orthostatic Hypotension
NCT00559871Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease
NCT03680365Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families